nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Ibuprofen—PPARG—colon cancer	0.00595	0.311	CrCbGaD
Sotalol—Eye irritation—Capecitabine—colon cancer	0.00543	0.00553	CcSEcCtD
Sotalol—Disorientation—Fluorouracil—colon cancer	0.00538	0.00549	CcSEcCtD
Sotalol—Visual disturbance—Irinotecan—colon cancer	0.0053	0.00541	CcSEcCtD
Sotalol—Pain in extremity—Vincristine—colon cancer	0.00516	0.00526	CcSEcCtD
Sotalol—Ventricular extrasystoles—Capecitabine—colon cancer	0.00513	0.00523	CcSEcCtD
Sotalol—Cerebrovascular accident—Irinotecan—colon cancer	0.00513	0.00523	CcSEcCtD
Sotalol—Amnesia—Fluorouracil—colon cancer	0.00512	0.00522	CcSEcCtD
Sotalol—Oropharyngeal pain—Capecitabine—colon cancer	0.0051	0.0052	CcSEcCtD
Sotalol—Paralysis—Methotrexate—colon cancer	0.00497	0.00506	CcSEcCtD
Sotalol—Cardiac failure—Fluorouracil—colon cancer	0.00493	0.00503	CcSEcCtD
Sotalol—Lethargy—Fluorouracil—colon cancer	0.00491	0.00501	CcSEcCtD
Sotalol—Atenolol—ABCB1—colon cancer	0.00479	0.25	CrCbGaD
Sotalol—Coordination abnormal—Capecitabine—colon cancer	0.00472	0.00481	CcSEcCtD
Sotalol—Cramp muscle—Irinotecan—colon cancer	0.00453	0.00461	CcSEcCtD
Sotalol—Abdominal distension—Irinotecan—colon cancer	0.00437	0.00446	CcSEcCtD
Sotalol—Angina pectoris—Irinotecan—colon cancer	0.00423	0.00431	CcSEcCtD
Sotalol—Eosinophilia—Fluorouracil—colon cancer	0.00412	0.0042	CcSEcCtD
Sotalol—Photosensitivity reaction—Vincristine—colon cancer	0.00407	0.00415	CcSEcCtD
Sotalol—Angina pectoris—Fluorouracil—colon cancer	0.00405	0.00413	CcSEcCtD
Sotalol—Upper respiratory tract infection—Irinotecan—colon cancer	0.00404	0.00412	CcSEcCtD
Sotalol—Depression—Vincristine—colon cancer	0.00397	0.00404	CcSEcCtD
Sotalol—Acute coronary syndrome—Vincristine—colon cancer	0.00392	0.004	CcSEcCtD
Sotalol—Myocardial infarction—Vincristine—colon cancer	0.0039	0.00397	CcSEcCtD
Sotalol—Neuropathy peripheral—Vincristine—colon cancer	0.0039	0.00397	CcSEcCtD
Sotalol—Sleep disorder—Capecitabine—colon cancer	0.00389	0.00396	CcSEcCtD
Sotalol—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00387	0.00394	CcSEcCtD
Sotalol—Acute coronary syndrome—Irinotecan—colon cancer	0.00382	0.00389	CcSEcCtD
Sotalol—Photosensitivity reaction—Fluorouracil—colon cancer	0.0038	0.00387	CcSEcCtD
Sotalol—Myocardial infarction—Irinotecan—colon cancer	0.0038	0.00387	CcSEcCtD
Sotalol—Vascular purpura—Capecitabine—colon cancer	0.00376	0.00383	CcSEcCtD
Sotalol—Metoprolol—ABCB1—colon cancer	0.00373	0.195	CrCbGaD
Sotalol—Acute coronary syndrome—Fluorouracil—colon cancer	0.00366	0.00373	CcSEcCtD
Sotalol—Neuropathy peripheral—Fluorouracil—colon cancer	0.00364	0.00371	CcSEcCtD
Sotalol—Myocardial infarction—Fluorouracil—colon cancer	0.00364	0.00371	CcSEcCtD
Sotalol—Amnesia—Capecitabine—colon cancer	0.00358	0.00365	CcSEcCtD
Sotalol—Bradycardia—Irinotecan—colon cancer	0.00354	0.00361	CcSEcCtD
Sotalol—Haemoglobin—Irinotecan—colon cancer	0.00349	0.00356	CcSEcCtD
Sotalol—Purpura—Capecitabine—colon cancer	0.00349	0.00356	CcSEcCtD
Sotalol—Haemorrhage—Irinotecan—colon cancer	0.00348	0.00355	CcSEcCtD
Sotalol—Agranulocytosis—Fluorouracil—colon cancer	0.00346	0.00353	CcSEcCtD
Sotalol—Cardiac failure—Capecitabine—colon cancer	0.00345	0.00351	CcSEcCtD
Sotalol—Lethargy—Capecitabine—colon cancer	0.00343	0.0035	CcSEcCtD
Sotalol—Cerebrovascular accident—Capecitabine—colon cancer	0.00343	0.0035	CcSEcCtD
Sotalol—Pain in extremity—Capecitabine—colon cancer	0.00336	0.00343	CcSEcCtD
Sotalol—Visual impairment—Irinotecan—colon cancer	0.00335	0.00342	CcSEcCtD
Sotalol—Haemoglobin—Fluorouracil—colon cancer	0.00335	0.00341	CcSEcCtD
Sotalol—Haemorrhage—Fluorouracil—colon cancer	0.00333	0.0034	CcSEcCtD
Sotalol—Angiopathy—Vincristine—colon cancer	0.00324	0.0033	CcSEcCtD
Sotalol—Mood swings—Capecitabine—colon cancer	0.00319	0.00325	CcSEcCtD
Sotalol—Alopecia—Vincristine—colon cancer	0.00316	0.00322	CcSEcCtD
Sotalol—Angiopathy—Irinotecan—colon cancer	0.00315	0.00322	CcSEcCtD
Sotalol—Arrhythmia—Irinotecan—colon cancer	0.00311	0.00317	CcSEcCtD
Sotalol—Alopecia—Irinotecan—colon cancer	0.00307	0.00313	CcSEcCtD
Sotalol—Pulmonary oedema—Methotrexate—colon cancer	0.00307	0.00313	CcSEcCtD
Sotalol—Back pain—Vincristine—colon cancer	0.00301	0.00307	CcSEcCtD
Sotalol—Flatulence—Irinotecan—colon cancer	0.00298	0.00304	CcSEcCtD
Sotalol—Arrhythmia—Fluorouracil—colon cancer	0.00298	0.00303	CcSEcCtD
Sotalol—Alopecia—Fluorouracil—colon cancer	0.00294	0.003	CcSEcCtD
Sotalol—Back pain—Irinotecan—colon cancer	0.00293	0.00299	CcSEcCtD
Sotalol—Abdominal distension—Capecitabine—colon cancer	0.00293	0.00298	CcSEcCtD
Sotalol—Muscle spasms—Irinotecan—colon cancer	0.00291	0.00297	CcSEcCtD
Sotalol—Asthma—Capecitabine—colon cancer	0.00291	0.00296	CcSEcCtD
Sotalol—Influenza—Capecitabine—colon cancer	0.00291	0.00296	CcSEcCtD
Sotalol—Bronchospasm—Capecitabine—colon cancer	0.00286	0.00292	CcSEcCtD
Sotalol—Angina pectoris—Capecitabine—colon cancer	0.00283	0.00289	CcSEcCtD
Sotalol—Vertigo—Vincristine—colon cancer	0.00279	0.00285	CcSEcCtD
Sotalol—Leukopenia—Vincristine—colon cancer	0.00278	0.00284	CcSEcCtD
Sotalol—Vision blurred—Fluorouracil—colon cancer	0.00273	0.00279	CcSEcCtD
Sotalol—Vertigo—Irinotecan—colon cancer	0.00272	0.00277	CcSEcCtD
Sotalol—Syncope—Irinotecan—colon cancer	0.00271	0.00277	CcSEcCtD
Sotalol—Leukopenia—Irinotecan—colon cancer	0.00271	0.00276	CcSEcCtD
Sotalol—Upper respiratory tract infection—Capecitabine—colon cancer	0.0027	0.00275	CcSEcCtD
Sotalol—Hypertension—Vincristine—colon cancer	0.00268	0.00274	CcSEcCtD
Sotalol—Loss of consciousness—Irinotecan—colon cancer	0.00266	0.00271	CcSEcCtD
Sotalol—Photosensitivity reaction—Capecitabine—colon cancer	0.00265	0.00271	CcSEcCtD
Sotalol—Myalgia—Vincristine—colon cancer	0.00265	0.0027	CcSEcCtD
Sotalol—Visual disturbance—Methotrexate—colon cancer	0.00264	0.00269	CcSEcCtD
Sotalol—Cough—Irinotecan—colon cancer	0.00264	0.00269	CcSEcCtD
Sotalol—Hyperglycaemia—Capecitabine—colon cancer	0.00262	0.00267	CcSEcCtD
Sotalol—Hypertension—Irinotecan—colon cancer	0.00261	0.00266	CcSEcCtD
Sotalol—Leukopenia—Fluorouracil—colon cancer	0.0026	0.00265	CcSEcCtD
Sotalol—Depression—Capecitabine—colon cancer	0.00259	0.00264	CcSEcCtD
Sotalol—Acute coronary syndrome—Capecitabine—colon cancer	0.00256	0.00261	CcSEcCtD
Sotalol—Lethargy—Methotrexate—colon cancer	0.00256	0.00261	CcSEcCtD
Sotalol—Cerebrovascular accident—Methotrexate—colon cancer	0.00256	0.00261	CcSEcCtD
Sotalol—Neuropathy peripheral—Capecitabine—colon cancer	0.00254	0.00259	CcSEcCtD
Sotalol—Myocardial infarction—Capecitabine—colon cancer	0.00254	0.00259	CcSEcCtD
Sotalol—Oedema—Vincristine—colon cancer	0.00254	0.00259	CcSEcCtD
Sotalol—Infection—Vincristine—colon cancer	0.00252	0.00257	CcSEcCtD
Sotalol—Ibuprofen—PTGS2—colon cancer	0.00251	0.131	CrCbGaD
Sotalol—Thrombocytopenia—Vincristine—colon cancer	0.00248	0.00253	CcSEcCtD
Sotalol—Oedema—Irinotecan—colon cancer	0.00247	0.00252	CcSEcCtD
Sotalol—Chest pain—Fluorouracil—colon cancer	0.00247	0.00252	CcSEcCtD
Sotalol—Myalgia—Fluorouracil—colon cancer	0.00247	0.00252	CcSEcCtD
Sotalol—Infection—Irinotecan—colon cancer	0.00245	0.0025	CcSEcCtD
Sotalol—Hyperhidrosis—Vincristine—colon cancer	0.00245	0.0025	CcSEcCtD
Sotalol—Shock—Irinotecan—colon cancer	0.00243	0.00248	CcSEcCtD
Sotalol—Agranulocytosis—Capecitabine—colon cancer	0.00242	0.00247	CcSEcCtD
Sotalol—Thrombocytopenia—Irinotecan—colon cancer	0.00242	0.00247	CcSEcCtD
Sotalol—Hyperhidrosis—Irinotecan—colon cancer	0.00239	0.00243	CcSEcCtD
Sotalol—Mood swings—Methotrexate—colon cancer	0.00237	0.00242	CcSEcCtD
Sotalol—Hypotension—Vincristine—colon cancer	0.00237	0.00242	CcSEcCtD
Sotalol—Bradycardia—Capecitabine—colon cancer	0.00237	0.00242	CcSEcCtD
Sotalol—Oedema—Fluorouracil—colon cancer	0.00237	0.00241	CcSEcCtD
Sotalol—Infection—Fluorouracil—colon cancer	0.00235	0.0024	CcSEcCtD
Sotalol—Haemoglobin—Capecitabine—colon cancer	0.00234	0.00238	CcSEcCtD
Sotalol—Haemorrhage—Capecitabine—colon cancer	0.00233	0.00237	CcSEcCtD
Sotalol—Thrombocytopenia—Fluorouracil—colon cancer	0.00232	0.00236	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00231	0.00236	CcSEcCtD
Sotalol—Hypotension—Irinotecan—colon cancer	0.00231	0.00235	CcSEcCtD
Sotalol—Insomnia—Vincristine—colon cancer	0.00229	0.00234	CcSEcCtD
Sotalol—Paraesthesia—Vincristine—colon cancer	0.00228	0.00232	CcSEcCtD
Sotalol—Visual impairment—Capecitabine—colon cancer	0.00224	0.00229	CcSEcCtD
Sotalol—Insomnia—Irinotecan—colon cancer	0.00223	0.00228	CcSEcCtD
Sotalol—Paraesthesia—Irinotecan—colon cancer	0.00222	0.00226	CcSEcCtD
Sotalol—Hypotension—Fluorouracil—colon cancer	0.00221	0.00225	CcSEcCtD
Sotalol—Decreased appetite—Vincristine—colon cancer	0.00221	0.00225	CcSEcCtD
Sotalol—Dyspnoea—Irinotecan—colon cancer	0.0022	0.00225	CcSEcCtD
Sotalol—Somnolence—Irinotecan—colon cancer	0.0022	0.00224	CcSEcCtD
Sotalol—Fatigue—Vincristine—colon cancer	0.00219	0.00223	CcSEcCtD
Sotalol—Dyspepsia—Irinotecan—colon cancer	0.00217	0.00222	CcSEcCtD
Sotalol—Pain—Vincristine—colon cancer	0.00217	0.00221	CcSEcCtD
Sotalol—Asthma—Methotrexate—colon cancer	0.00216	0.00221	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00216	0.0022	CcSEcCtD
Sotalol—Decreased appetite—Irinotecan—colon cancer	0.00215	0.00219	CcSEcCtD
Sotalol—Eosinophilia—Methotrexate—colon cancer	0.00214	0.00218	CcSEcCtD
Sotalol—Insomnia—Fluorouracil—colon cancer	0.00214	0.00218	CcSEcCtD
Sotalol—Ibuprofen—ABCB1—colon cancer	0.00214	0.112	CrCbGaD
Sotalol—Fatigue—Irinotecan—colon cancer	0.00213	0.00217	CcSEcCtD
Sotalol—Paraesthesia—Fluorouracil—colon cancer	0.00212	0.00217	CcSEcCtD
Sotalol—Pain—Irinotecan—colon cancer	0.00211	0.00215	CcSEcCtD
Sotalol—Angiopathy—Capecitabine—colon cancer	0.00211	0.00215	CcSEcCtD
Sotalol—Dyspnoea—Fluorouracil—colon cancer	0.00211	0.00215	CcSEcCtD
Sotalol—Somnolence—Fluorouracil—colon cancer	0.0021	0.00214	CcSEcCtD
Sotalol—Dyspepsia—Fluorouracil—colon cancer	0.00208	0.00212	CcSEcCtD
Sotalol—Arrhythmia—Capecitabine—colon cancer	0.00208	0.00212	CcSEcCtD
Sotalol—Gastrointestinal pain—Vincristine—colon cancer	0.00207	0.00211	CcSEcCtD
Sotalol—Decreased appetite—Fluorouracil—colon cancer	0.00206	0.0021	CcSEcCtD
Sotalol—Alopecia—Capecitabine—colon cancer	0.00206	0.0021	CcSEcCtD
Sotalol—Pain—Fluorouracil—colon cancer	0.00202	0.00206	CcSEcCtD
Sotalol—Gastrointestinal pain—Irinotecan—colon cancer	0.00202	0.00206	CcSEcCtD
Sotalol—Upper respiratory tract infection—Methotrexate—colon cancer	0.00201	0.00205	CcSEcCtD
Sotalol—Abdominal pain—Vincristine—colon cancer	0.00201	0.00204	CcSEcCtD
Sotalol—Body temperature increased—Vincristine—colon cancer	0.00201	0.00204	CcSEcCtD
Sotalol—Flatulence—Capecitabine—colon cancer	0.002	0.00204	CcSEcCtD
Sotalol—Dysgeusia—Capecitabine—colon cancer	0.00198	0.00202	CcSEcCtD
Sotalol—Photosensitivity reaction—Methotrexate—colon cancer	0.00198	0.00201	CcSEcCtD
Sotalol—Back pain—Capecitabine—colon cancer	0.00196	0.002	CcSEcCtD
Sotalol—Body temperature increased—Irinotecan—colon cancer	0.00195	0.00199	CcSEcCtD
Sotalol—Abdominal pain—Irinotecan—colon cancer	0.00195	0.00199	CcSEcCtD
Sotalol—Muscle spasms—Capecitabine—colon cancer	0.00195	0.00199	CcSEcCtD
Sotalol—Drowsiness—Methotrexate—colon cancer	0.00193	0.00197	CcSEcCtD
Sotalol—Depression—Methotrexate—colon cancer	0.00192	0.00196	CcSEcCtD
Sotalol—Vision blurred—Capecitabine—colon cancer	0.00191	0.00195	CcSEcCtD
Sotalol—Body temperature increased—Fluorouracil—colon cancer	0.00187	0.00191	CcSEcCtD
Sotalol—Vertigo—Capecitabine—colon cancer	0.00182	0.00186	CcSEcCtD
Sotalol—Asthenia—Vincristine—colon cancer	0.00182	0.00186	CcSEcCtD
Sotalol—Syncope—Capecitabine—colon cancer	0.00182	0.00185	CcSEcCtD
Sotalol—Leukopenia—Capecitabine—colon cancer	0.00181	0.00185	CcSEcCtD
Sotalol—Agranulocytosis—Methotrexate—colon cancer	0.0018	0.00184	CcSEcCtD
Sotalol—Palpitations—Capecitabine—colon cancer	0.00179	0.00183	CcSEcCtD
Sotalol—Loss of consciousness—Capecitabine—colon cancer	0.00178	0.00182	CcSEcCtD
Sotalol—Asthenia—Irinotecan—colon cancer	0.00177	0.00181	CcSEcCtD
Sotalol—Cough—Capecitabine—colon cancer	0.00177	0.0018	CcSEcCtD
Sotalol—Hypertension—Capecitabine—colon cancer	0.00175	0.00178	CcSEcCtD
Sotalol—Haemoglobin—Methotrexate—colon cancer	0.00174	0.00178	CcSEcCtD
Sotalol—Diarrhoea—Vincristine—colon cancer	0.00174	0.00177	CcSEcCtD
Sotalol—Haemorrhage—Methotrexate—colon cancer	0.00173	0.00177	CcSEcCtD
Sotalol—Chest pain—Capecitabine—colon cancer	0.00172	0.00176	CcSEcCtD
Sotalol—Myalgia—Capecitabine—colon cancer	0.00172	0.00176	CcSEcCtD
Sotalol—Anxiety—Capecitabine—colon cancer	0.00172	0.00175	CcSEcCtD
Sotalol—Diarrhoea—Irinotecan—colon cancer	0.00169	0.00172	CcSEcCtD
Sotalol—Dizziness—Vincristine—colon cancer	0.00168	0.00171	CcSEcCtD
Sotalol—Pruritus—Fluorouracil—colon cancer	0.00167	0.00171	CcSEcCtD
Sotalol—Visual impairment—Methotrexate—colon cancer	0.00167	0.0017	CcSEcCtD
Sotalol—Oedema—Capecitabine—colon cancer	0.00165	0.00169	CcSEcCtD
Sotalol—Infection—Capecitabine—colon cancer	0.00164	0.00167	CcSEcCtD
Sotalol—Dizziness—Irinotecan—colon cancer	0.00163	0.00167	CcSEcCtD
Sotalol—Shock—Capecitabine—colon cancer	0.00163	0.00166	CcSEcCtD
Sotalol—Diarrhoea—Fluorouracil—colon cancer	0.00162	0.00165	CcSEcCtD
Sotalol—Thrombocytopenia—Capecitabine—colon cancer	0.00162	0.00165	CcSEcCtD
Sotalol—Vomiting—Vincristine—colon cancer	0.00161	0.00164	CcSEcCtD
Sotalol—Rash—Vincristine—colon cancer	0.0016	0.00163	CcSEcCtD
Sotalol—Hyperhidrosis—Capecitabine—colon cancer	0.0016	0.00163	CcSEcCtD
Sotalol—Dermatitis—Vincristine—colon cancer	0.0016	0.00163	CcSEcCtD
Sotalol—Headache—Vincristine—colon cancer	0.00159	0.00162	CcSEcCtD
Sotalol—Angiopathy—Methotrexate—colon cancer	0.00157	0.0016	CcSEcCtD
Sotalol—Vomiting—Irinotecan—colon cancer	0.00157	0.0016	CcSEcCtD
Sotalol—Dizziness—Fluorouracil—colon cancer	0.00156	0.0016	CcSEcCtD
Sotalol—Rash—Irinotecan—colon cancer	0.00156	0.00159	CcSEcCtD
Sotalol—Dermatitis—Irinotecan—colon cancer	0.00156	0.00159	CcSEcCtD
Sotalol—Headache—Irinotecan—colon cancer	0.00155	0.00158	CcSEcCtD
Sotalol—Hypotension—Capecitabine—colon cancer	0.00155	0.00158	CcSEcCtD
Sotalol—Alopecia—Methotrexate—colon cancer	0.00153	0.00156	CcSEcCtD
Sotalol—Nausea—Vincristine—colon cancer	0.00151	0.00154	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00151	0.00154	CcSEcCtD
Sotalol—Vomiting—Fluorouracil—colon cancer	0.0015	0.00153	CcSEcCtD
Sotalol—Insomnia—Capecitabine—colon cancer	0.0015	0.00152	CcSEcCtD
Sotalol—Rash—Fluorouracil—colon cancer	0.00149	0.00152	CcSEcCtD
Sotalol—Dermatitis—Fluorouracil—colon cancer	0.00149	0.00152	CcSEcCtD
Sotalol—Paraesthesia—Capecitabine—colon cancer	0.00148	0.00151	CcSEcCtD
Sotalol—Headache—Fluorouracil—colon cancer	0.00148	0.00151	CcSEcCtD
Sotalol—Dysgeusia—Methotrexate—colon cancer	0.00148	0.00151	CcSEcCtD
Sotalol—Dyspnoea—Capecitabine—colon cancer	0.00147	0.0015	CcSEcCtD
Sotalol—Nausea—Irinotecan—colon cancer	0.00147	0.0015	CcSEcCtD
Sotalol—Back pain—Methotrexate—colon cancer	0.00146	0.00149	CcSEcCtD
Sotalol—Dyspepsia—Capecitabine—colon cancer	0.00146	0.00148	CcSEcCtD
Sotalol—Decreased appetite—Capecitabine—colon cancer	0.00144	0.00147	CcSEcCtD
Sotalol—Fatigue—Capecitabine—colon cancer	0.00143	0.00145	CcSEcCtD
Sotalol—Vision blurred—Methotrexate—colon cancer	0.00142	0.00145	CcSEcCtD
Sotalol—Pain—Capecitabine—colon cancer	0.00141	0.00144	CcSEcCtD
Sotalol—Nausea—Fluorouracil—colon cancer	0.00141	0.00143	CcSEcCtD
Sotalol—Vertigo—Methotrexate—colon cancer	0.00136	0.00138	CcSEcCtD
Sotalol—Gastrointestinal pain—Capecitabine—colon cancer	0.00135	0.00138	CcSEcCtD
Sotalol—Leukopenia—Methotrexate—colon cancer	0.00135	0.00138	CcSEcCtD
Sotalol—Cough—Methotrexate—colon cancer	0.00132	0.00134	CcSEcCtD
Sotalol—Abdominal pain—Capecitabine—colon cancer	0.00131	0.00133	CcSEcCtD
Sotalol—Body temperature increased—Capecitabine—colon cancer	0.00131	0.00133	CcSEcCtD
Sotalol—Chest pain—Methotrexate—colon cancer	0.00128	0.00131	CcSEcCtD
Sotalol—Myalgia—Methotrexate—colon cancer	0.00128	0.00131	CcSEcCtD
Sotalol—Infection—Methotrexate—colon cancer	0.00122	0.00125	CcSEcCtD
Sotalol—Thrombocytopenia—Methotrexate—colon cancer	0.00121	0.00123	CcSEcCtD
Sotalol—Hyperhidrosis—Methotrexate—colon cancer	0.00119	0.00121	CcSEcCtD
Sotalol—Asthenia—Capecitabine—colon cancer	0.00119	0.00121	CcSEcCtD
Sotalol—Pruritus—Capecitabine—colon cancer	0.00117	0.00119	CcSEcCtD
Sotalol—Hypotension—Methotrexate—colon cancer	0.00115	0.00117	CcSEcCtD
Sotalol—Diarrhoea—Capecitabine—colon cancer	0.00113	0.00115	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00112	0.00114	CcSEcCtD
Sotalol—Insomnia—Methotrexate—colon cancer	0.00111	0.00113	CcSEcCtD
Sotalol—Paraesthesia—Methotrexate—colon cancer	0.00111	0.00113	CcSEcCtD
Sotalol—Dyspnoea—Methotrexate—colon cancer	0.0011	0.00112	CcSEcCtD
Sotalol—Somnolence—Methotrexate—colon cancer	0.00109	0.00112	CcSEcCtD
Sotalol—Dizziness—Capecitabine—colon cancer	0.00109	0.00111	CcSEcCtD
Sotalol—Dyspepsia—Methotrexate—colon cancer	0.00108	0.0011	CcSEcCtD
Sotalol—Decreased appetite—Methotrexate—colon cancer	0.00107	0.00109	CcSEcCtD
Sotalol—Fatigue—Methotrexate—colon cancer	0.00106	0.00108	CcSEcCtD
Sotalol—Pain—Methotrexate—colon cancer	0.00105	0.00107	CcSEcCtD
Sotalol—Vomiting—Capecitabine—colon cancer	0.00105	0.00107	CcSEcCtD
Sotalol—Rash—Capecitabine—colon cancer	0.00104	0.00106	CcSEcCtD
Sotalol—Dermatitis—Capecitabine—colon cancer	0.00104	0.00106	CcSEcCtD
Sotalol—Headache—Capecitabine—colon cancer	0.00104	0.00106	CcSEcCtD
Sotalol—Gastrointestinal pain—Methotrexate—colon cancer	0.00101	0.00103	CcSEcCtD
Sotalol—Nausea—Capecitabine—colon cancer	0.000982	0.001	CcSEcCtD
Sotalol—Abdominal pain—Methotrexate—colon cancer	0.000973	0.000992	CcSEcCtD
Sotalol—Body temperature increased—Methotrexate—colon cancer	0.000973	0.000992	CcSEcCtD
Sotalol—Asthenia—Methotrexate—colon cancer	0.000883	0.0009	CcSEcCtD
Sotalol—Pruritus—Methotrexate—colon cancer	0.000871	0.000888	CcSEcCtD
Sotalol—Diarrhoea—Methotrexate—colon cancer	0.000842	0.000859	CcSEcCtD
Sotalol—Dizziness—Methotrexate—colon cancer	0.000814	0.00083	CcSEcCtD
Sotalol—Vomiting—Methotrexate—colon cancer	0.000783	0.000798	CcSEcCtD
Sotalol—Rash—Methotrexate—colon cancer	0.000776	0.000791	CcSEcCtD
Sotalol—Dermatitis—Methotrexate—colon cancer	0.000775	0.00079	CcSEcCtD
Sotalol—Headache—Methotrexate—colon cancer	0.000771	0.000786	CcSEcCtD
Sotalol—Nausea—Methotrexate—colon cancer	0.000731	0.000745	CcSEcCtD
